题名 | A phase 2, proof-of-concept, placebo-controlled, randomized, multicenter, double-blind study to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of Usnoflast (ZYIL1) in patients with amyotrophic lateral sclerosis |
链接 | https://pubmed.ncbi.nlm.nih.gov/40511876/ |
https://pubmed.ncbi.nlm.nih.gov/40511876/
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |